Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis

BACKGROUND: Xuesaitong Injection (XST) is one of the most commonly used medicines for treating acute cerebral infarction (ACI) in China. However, compared to the conventional therapy with western medicines (WM), the effectiveness and safety of XST as an adjuvant treatment for ACI needs to be systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaomeng, Wu, Jiarui, Zhang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355548/
https://www.ncbi.nlm.nih.gov/pubmed/25888429
http://dx.doi.org/10.1186/s12906-015-0560-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355548/
https://www.ncbi.nlm.nih.gov/pubmed/25888429
http://dx.doi.org/10.1186/s12906-015-0560-4

Ejemplares similares